Evidence map›Paper›PMID 37746258›Full record

ReviewFrontiers in oncology2023

Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment.

Megha Yadav, Blessi N Uikey, Shantnu Singh Rathore, Priyanka Gupta, Diksha Kashyap, Chanchal Kumar, Dhananjay Shukla, Vijayamahantesh, Arvind Singh Chandel, Bharti Ahirwar and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Central Roles of Glucosylceramide in Driving Cancer Pathogenesis.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Megha YadavDepartment of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, India.
Blessi N UikeyDepartment of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, India.
Shantnu Singh RathoreDepartment of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, India.
Priyanka GuptaDepartment of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, India.
Diksha KashyapDepartment of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, India.
Chanchal KumarDepartment of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, India.
Dhananjay ShuklaDepartment of Biotechnology, Guru Ghasidas Vishwavidyalaya, Bilaspur, India.
VijayamahanteshDepartment of Immunology and Microbiology, University of Missouri, Columbia, SC, United States.
Arvind Singh ChandelCenter for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Bunkyo, Japan.
Bharti AhirwarDepartment of Pharmacy, Guru Ghasidas Vishwavidyalaya, Bilaspur, India.
Ashish Kumar SinghDepartment of Microbiology, RK University, Rajkot, India.
Shashi Shekhar SumanDepartment of Zoology, Udayana Charya (UR) College, Lalit Narayan Mithila University, Darbhanga, India.
Amit PriyadarshiDepartment of Zoology, Veer Kunwar Singh University, Arrah, India.
Ajay AmitDepartment of Forensic Science, Guru Ghasidas Vishwavidyalaya, Bilaspur, India.
Guru Ghasidas Vishwavidyalaya · INLalit Narayan Mithila University · INRK University · INThe University of Tokyo · JPUniversity of Missouri · USVeer Kunwar Singh University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cells are an important component of adaptive immunity and T-cell-derived lymphomas are very complex due to many functional sub-types and functional elasticity of T-cells. As with other tumors, tissues specific factors are crucial in the development of T-cell lymphomas. In addition to neoplastic cells, T- cell lymphomas consist of a tumor micro-environment composed of normal cells and stroma. Numerous studies established the qualitative and quantitative differences between the tumor microenvironment and normal cell surroundings. Interaction between the various component of the tumor microenvironment is crucial since tumor cells can change the microenvironment and vice versa. In normal T-cell development, T-cells must respond to various stimulants deferentially and during these courses of adaptation. T-cells undergo various metabolic alterations. From the stage of quiescence to attention of fully active form T-cells undergoes various stage in terms of metabolic activity. Predominantly quiescent T-cells have ATP-generating metabolism while during the proliferative stage, their metabolism tilted towards the growth-promoting pathways. In addition to this, a functionally different subset of T-cells requires to activate the different metabolic pathways, and consequently, this regulation of the metabolic pathway control activation and function of T-cells. So, it is obvious that dynamic, and well-regulated metabolic pathways are important for the normal functioning of T-cells and their interaction with the microenvironment. There are various cell signaling mechanisms of metabolism are involved in this regulation and more and more studies have suggested the involvement of additional signaling in the development of the overall metabolic phenotype of T cells. These important signaling mediators include cytokines and hormones. The impact and role of these mediators especially the cytokines on the interplay between T-cell metabolism and the interaction of T-cells with their micro-environments in the context of T-cells lymphomas are discussed in this review article.

Indexed as

cell signalingcytokinemetabolismT cell lymphomatumor micro environment

Identifiers

PMID37746258
PMCPMC10513393
OpenAlexW4386494255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.